Image-01 (Image 01)
This is "venlafaxine hydrochloride," a medication used to treat depression and anxiety disorders.*
Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-8694
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-8694). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-02 (Image 02)
This description provides information on special populations with hepatic and renal impairments, genetic variations in CYP2D6 polymorphism, age considerations (>80 years), gender differences, and specific analyte variations related to venlafaxine. It also mentions fold change and confidence intervals in pharmacokinetics. Additionally, it includes data related to changes relative to the reference value.*
Image-03 (Image 03)
This text offers information on the potential changes in pharmacokinetics (PK) for various drug analytes when interacting with venlafaxine and other drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. It mentions parameters like Cmax (maximum concentration) and AUC (area under the curve), and discusses the observed changes and fold changes with a confidence interval of 90%. The text does not provide specific numerical values but outlines the PK fold changes for each drug interaction, highlighting potential alterations in drug levels when combined with venlafaxine.*
Image-04 (Image 04)
The text provided lists a variety of drugs and analytes, including their interactions and active moieties. It also mentions fold change and 90% CI relative to reference values. The drugs mentioned include Ethanor, Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium. The active moieties and metabolites of some drugs like Diazepam and Imipramine are also identified. The text seems to be related to pharmacological interactions and concentrations of these substances.*
Venlafaxine HCl Extended-release Capsules 75mg (Strength 2 30ct)
This is a description of Venlafaxine HCI Extended-Release Capsules 75mg, a generic version of Effexor ER. Each capsule contains Venlafaxine hydrochloride, USP equivalent to 75mg of venlafaxine. The capsule is orange and gray and imprinted with YH 129. The medication should be stored at 20°-25°C (68°-77°F) with excursions permitted to 15°-30°C (59°-86°F). It is important to keep this medication out of reach of children. The text also includes instructions in Spanish and a caution about the federal law prohibiting the transfer of this drug to anyone other than the prescribed patient. The manufacturer is Yichang Humanwell Oral Solid Dosage Plant.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
